Jasper Accounts Payable from 2010 to 2025

JSPRW Stock  USD 0.12  0.01  6.38%   
Jasper Therapeutics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 2.9 M in 2025. Accounts Payable is the amount Jasper Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents Jasper Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-12-31
Previous Quarter
3.1 M
Current Value
M
Quarterly Volatility
1.5 M
 
Covid
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 13.1 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.31. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Jasper Therapeutics Correlation against competitors.
For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.

Latest Jasper Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Jasper Therapeutics over the last few years. An accounting item on the balance sheet that represents Jasper Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Jasper Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Jasper Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Jasper Accounts Payable Regression Statistics

Arithmetic Mean1,526,597
Geometric Mean1,094,043
Coefficient Of Variation91.11
Mean Deviation1,143,196
Median623,000
Standard Deviation1,390,850
Sample Variance1.9T
Range3.5M
R-Value0.78
Mean Square Error814.5B
R-Squared0.61
Significance0.0004
Slope227,608
Total Sum of Squares29T

Jasper Accounts Payable History

20252.9 M
2024M
20234.1 M
20221.8 M
20213.9 M
20201.4 M

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts PayableM2.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.